US2003167141A1PendingUtilityA1
Structural health monitoring
Priority: Dec 20, 2001Filed: Dec 20, 2001Published: Sep 4, 2003
Est. expiryDec 20, 2021(expired)· nominal 20-yr term from priority
Inventors:Wieslaw Staszewski
G01N 29/075G01N 29/46G01N 29/50
14
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to testing structures or bodies to determine if they contain defects. The defects may be, for example, cracks, delamination etc. Conventional non-destructive testing exploits the non-linearities of such defects. The non-linearities produce intermodulation products in the form of side-bands of an excitation signal. The amplitudes of the side-bands are used to provide an indication of the structural health of the body. However, it has been found that such methods of testing bodies suffer from the vagaries of the environment, temperature and transducer manufacturing tolerances etc. This can lead to inaccurate test results. Suitably, the present invention provides a method for testing a body; the method comprising the steps of comparing first data, representing an excitation signal launched into the body to produce a guided wave within the body, with second data, derived from the body while bearing the guided wave, to identify a phase difference between the first and second data; and determining a measure of the structural integrity of the body using the phase difference. By basing the assessment of the structural body on defect induced phase modulation, more accurate testing can be performed that is independent of at least some of the above-mentioned vagaries.
Claims
exact text as granted — not AI-modified1 . A method of determining the structural health of a body; the method comprising the steps of identifying at least one phase characteristic of a signal represented by first data, the first data being derived from the body while bearing at least a guided wave produced in response to application of at least one excitation signal to the body, and providing a measure of the structural health of the body using the at least one phase characteristic.
2 . A method as claimed in any preceding claim, in which the step of identifying the phase characteristic comprises the step of calculating a phase modulation of the first data using
φ
(
t
)
=
arctan
x
^
(
t
)
x
(
t
)
,
where {circumflex over (x)}(t) is the Hilbert transform of the signal represented by the first data and x(t) is the signal represented by the first data.
3 . A method as claimed in claim 2 , in which the step of providing the measure of structural health comprises the step of determining the amplitude of the phase modulation.
4 . A method as claimed in claim 3 , in which the step of determining the amplitude of the phase modulation comprises the step of determining the maximum amplitude of the phase modulation.
5 . A method as claimed in any preceding claim, in which the step of identifying comprise the steps of taking the Fourier transform of the first data and applying the convolution theorem which gives
F[{circumflex over (x)} ( t )]= {circumflex over (X)} ( f )= X ( f ){− jsgn ( f )},
where sgn(t) is the signum function defined as
sgn
(
f
)
=
{
1
for
f
≥
0
-
1
for
f
<
0
,
where
f
is
frequency
.
6 . A method as claimed in claim 1 , in which the step of identifying comprises the step of comparing the first data with second data, representing the excitation signal launched into the body to produce a guided wave within the body, to identify a phase difference between the first and second data; and in which the at least one phase characteristic comprises the phase difference.
7 . A method as claimed in claim 1 , in which the step of identifying comprises the step of comparing the firs data with second data, representing a previously determined response of the body to bearing a guided wave produced in response to the excitation signal being launched into the body, to identify a phase difference between the first and second data; and in which the at least one phase, characteristic comprises the phase difference.
8 . A method as claimed in either of claims 6 and 7 , in which the phase difference is calculated using a cross-correlation function
R
(
τ
)
=
∑
t
=
1
N
x
ref
(
t
)
x
(
t
+
τ
)
,
where R(τ i ) is the cross-correlation function between the first and second data and N is the number of data samples of the first and second data.
9 . A method as claimed in claim 8 , in which the measure of structural health is given by at least one of D=1−R(τ i ) or D=1/R(τ i ).
10 . A method as claimed in any of claims 6 to 9 , in which the step of providing comprises the step of identifying the magnitude of the instantaneous phase difference between the first and second data.
11 . A method as claimed in any preceding claim, in which the guided wave is a Lamb wave.
12 . A method as claimed in any preceding claim, further comprising the steps of attaching a first transducer to file body and applying the excitation signal to the first transducer to induce the propagation of the guided wave within the body.
13 . A method as claimed in any preceding claim, further comprising the step of attaching a second transducer to the body and measure the response of the second transducer to the presence of the guided wave.
14 . A method as claimed in any preceding claim, further comprising the steps of applying a third transducer to the body and applying a second excitation signal to the third transducer.
15 . A method as claimed in any preceding claim, in which the excitation signal applied to a transducer is arranged to produce a guided wave having a predetermined frequency.
16 . A method as claimed in claim 15 , in which the predetermined frequency is selected according to the dimensions of an anticipated defect within the body.
17 . A method as claimed in any preceding claim, in which the excitation signal is arranged to have at least one predetermined frequency component.
18 . A method as claimed in claim 17 , in which the at least one predetermined frequency component comprises at least one frequency component that is related to at least one of a desired mode of propagation of the guided wave and the thickness of the material under test, preferably, the at least one predetermined frequency component comprises at least one frequency component in the range 80 kHz to 10 MHz.
19 . A method as claimed in either of claims 17 and 18 , in which the at least one predetermined frequency component comprises at least one frequency component in the range 1 Hz to 10 kHz.
20 . A method as claimed in any preceding claim, in which the excitation frequency is selected to induce a predetermined mode of propagation of the guided wave within the body.
21 . A method as claimed in any preceding claim, in which the excitation signal predetermined frequency is selected according to a resonant mode of the first transducer.
22 . A method as claimed in any of claims 6 and 21 , in which the step of providing the measure of structural health comprises the step of comparing the amplitude of the phase modulation with the amplitude of the excitation signal.
23 . A method for monitoring the structural integrity of a body substantially as described herein with reference to and/or as illustrated in the accompanying drawings.
24 . An apparatus for determining the structural health of a body; the apparatus comprising means for identifying at least one phase characteristic of a signal represented by first data, the fist data being derived from the body while bearing at least a guided wave produced in response to application of at least one excitation signal to the body, and means for providing a measure of the structural health of the body using the at least one phase characteristic.
25 . An apparatus as claimed in claim 24 , in which the means for identifying the phase characteristic comprises means for calculating a phase modulation of the first data using
φ
(
t
)
=
arctan
x
^
(
t
)
x
(
t
)
,
where {circumflex over (x)}(t) is the Hilbert transform of the signal represented by the first data and x(t) is the signal represented by the first data.
26 . An apparatus as claimed in claim 25 , in which the means for providing the measure of structural health comprises means for determining the amplitude of the phase modulation.
27 . An apparatus as claimed in claim 26 , in which the means for determining the amplitude of the phase modulation comprises means for determining the maximum amplitude of the phase modulation.
28 . An apparatus as claimed in any of claims 24 to 27 , in which the means for identifying comprises means for taking the Fourier transform of the first data and means for applying the convolution theorem which gives
F[{circumflex over (x)} ( t )]= {circumflex over (X)} ( f )= X ( f ){− jsgn ( f )},
where sgn(f) is the signum function defined as
sgn
(
f
)
=
{
1
for
f
≥
0
-
1
for
f
<
0
,
where
f
is
frequency
.
29 . All apparatus as claimed in claim 24 , in which the means for identifying comprises means for comparing the first data with second data, representing the excitation signal launched into the body to produce a guided wave within the body, to identify a phase difference between the first and second data; and in which the at least one phase characteristic comprises the phase difference.
30 . An apparatus as claimed in claim 24 , in which the means for identifying comprises means for comparing the first data with second data, representing a previously determined response of the body to bearing a guided wave produced in response to the excitation signal launched being launched into the body, to identify a phase difference between the first and second data; and in which the at least one phase characteristic comprises the phase difference.
31 . An apparatus as claimed in either of claims 29 and 30 , in which the phase difference is calculated using a cross-correlation function
R
(
τ
)
=
∑
t
=
1
N
x
ref
(
t
)
x
(
t
+
τ
)
,
where R(τ i ) is the cross-correlation function between the first and second data and N is the number of data samples of the first and second data.
32 . An apparatus as cleaned in claim 31 , in which the measure of structure health is given by at least one of D=1−R(τ i ) or D=1/R(τ i ).
33 . An apparatus as claimed in any of claims 29 to 32 , in which the means for providing comprises means for identifying the Solitude of the instantaneous phase difference between the first and second data.
34 . An apparatus as claimed in any of claims 24 to 33 , in which the guided wave is a Lamb wave.
35 . An apparatus as claimed in any of claims 24 to 34 , flier comprising means for attaching a first transducer to the body and means for applying the excitation signal to the first transducer to induce the propagation of the guided wave with the body.
36 . An apparatus as claimed in any of claims 24 to 35 , further comprising means for attaching a second transducer to the body, and means for measuring the response of the second transducer to the presence of the guided wave.
37 . An apparatus as claimed in any of claims 24 to 36 , further comprising means for applying a third transducer to the body and means for applying a second excitation signal to the third transducer.
38 . An apparatus as claimed in any of claims 24 to 37 , in which the excitation signal applied to the transducer is arranged to produce a guided wave having a predetermined frequency.
39 . An apparatus as claimed in claim 38 , in which the predetermined frequency is selected according to the dimensions of an anticipated defect within the body.
40 . An apparatus as claimed in any of claims 24 to 39 , in which the excitation signal is arranged to have at least one predetermined frequency component.
41 . An apparatus as claimed in claim 40 , in which the at least one predetermined frequency component comprises at least one frequency component that is related to at least one of desired mode of propagation of the guided wave and the thickness of the material under test and preferably comprises at least one frequency component in the range 80 kHz to 10 MHz.
42 . An apparatus as claimed in either of claims 40 and 41 , in which the at least one predetermined frequency component comprises at least one frequency component in the range 1 Hz to 10 kHz.
43 . An apparatus as claimed in any of claims 24 to 42 , in which the excitation frequency is selected to induce a predetermined mode of propagation of the guided wave within the body.
44 . An apparatus as clamed in any of claims 24 to 43 , in which the excitation signal predetermined frequency is selected according to a resonant mode of the first transducer.
45 . An apparatus as claimed in any of 24 to 44 , in which the means for providing the measure of structural health comprises means for comparing the amplitude of the phase modulation with the amplitude of the excitation signal.
46 . An apparatus for monitoring the structural integrity of a body substantially as described herein with reference to and/or as illustrated in the accompanying drawings.
47 . A computer program element for implementing a method or system as claimed in any preceding claim.
48 . A computer program product comprising a computer readable storage medium having stored thereon a computer program element as claimed in claim 47.Join the waitlist — get patent alerts
Track US2003167141A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.